Dr. Dipankar Manna

Prof. Ute Krengel Lab University of Oslo, Norway Mob: +47 451 66 517 E-mail: dipankar.biotech@gmail.com, dipankar.manna@medisin.uio.no

📍 Oslo, Norway

When will COVID-19 vaccines be available for children under 12 years of age?

Although the corona vaccine is available in the market, it is only approved for use by those 18 years of age and older. However, only one of these vaccines is available for children ages 12 years and up. The rest of the vaccines are in various stages of clinical trials

SARS-CoV-2 Delta variant: a new potential threat

The fast-spreading Delta variant (B.1.617.2) of SARS-CoV-2 is crumbling the precious progress against the COVID-19 pandemic, even in countries that seemed to have the corona infection under control. With 60% more transmissibility, Delta variant is considered as the most hypertransmissible contagious variant identified to date and reported

Repurposed drugs to fight COVID-19: most debated drugs that failed to perform

Since the beginning of the COVID-19 pandemic, the number of corona infected cases continues to increase. The disease is new, so there were no treatment options available by then. Several drugs, despite lack of evidence on effectiveness, were repurposed in the first few months of the pandemic to quickly get

The future of COVID-19 vaccines is expected to be better, but the mutants are of special concern

COVID-19 vaccines created a historical landmark as the quickest developed vaccine in the vaccine catalogue. Monumental technological advancement and enormous support and collaboration among scientific groups around the globe made it possible. Since the beginning of the pandemic, science has uncovered a lot about SARS-CoV-2 and achieved extraordinary milestones on